{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:20:06Z","timestamp":1787498406412,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.neurol.2017.12.003","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T08:12:13Z","timestamp":1534579933000},"page":"699-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Parkinson's disease pathogenesis, evolution and alternative pathways: A review"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8137-8253","authenticated-orcid":false,"given":"A.","family":"Alexoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Alexoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gatzonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2017.12.003_bib0400","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.22796","article-title":"Parkinson's disease: 10 years of progress, 1997\u20132007","volume":"25","author":"Fahn","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2017.12.003_bib0405","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neurol.2012.07.004","article-title":"When does Parkinson's disease begin? From prodromal disease to motor signs","volume":"168","author":"Meissner","year":"2012","journal-title":"Rev Neurol (Paris)"},{"issue":"Suppl. 6","key":"10.1016\/j.neurol.2017.12.003_bib0410","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger","year":"2003","journal-title":"Move Disord"},{"key":"10.1016\/j.neurol.2017.12.003_bib0415","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2017.12.003_bib0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2017.12.003_bib0425","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ene.12753","article-title":"Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature","volume":"23","author":"Schneider","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0430","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0435","first-page":"21","article-title":"The potential role of microorganisms in the development of rosacea","volume":"9","author":"Lazaridou","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.neurol.2017.12.003_bib0440","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0445","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0450","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between Rosacea and Parkinson disease: a danish nationwide cohort study","volume":"5","author":"Egeberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0455","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0625.1997.tb00164.x","article-title":"Matrix metalloproteinases in skin","volume":"6","author":"Kahari","year":"1997","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0460","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2010.03825.x","article-title":"Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea","volume":"25","author":"Jang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0465","doi-asserted-by":"crossref","first-page":"370526","DOI":"10.1155\/2013\/370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease","volume":"2013","author":"Chung","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.neurol.2017.12.003_bib0470","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00429-014-0718-8","article-title":"Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism","volume":"220","author":"Annese","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neurol.2017.12.003_bib0475","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2015.5549","article-title":"Association of rosacea with risk for glioma in a Danish Nationwide Cohort Study","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0480","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamaneurol.2016.2321","article-title":"Association between Rosacea and Parkinson disease","volume":"9","author":"Alexoudi","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0485","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clindermatol.2014.04.010","article-title":"Segmental immune disorders resulting from neurologic injuries","volume":"32","author":"Piccolo","year":"2014","journal-title":"Clinics Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0490","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0190-9622(90)70100-V","article-title":"Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis","volume":"22","author":"Kieffer","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0495","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1346-8138.2008.00523.x","article-title":"Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents","volume":"35","author":"Zhang","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0500","article-title":"Treatment of seborrheic dermatitis","volume":"61","author":"Johnson","year":"2000","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.neurol.2017.12.003_bib0505","article-title":"Seborrheic dermatitis","volume":"52","author":"Janniger","year":"1995","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.neurol.2017.12.003_bib0510","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archderm.1983.01650300027010","article-title":"Seborrheic dermatitis in neuroleptic-induced parkinsonism","volume":"119","author":"Binder","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0515","first-page":"125","article-title":"Seborrheic dermatitis: a newly reported side effect of neuroleptics","volume":"45","author":"Binder","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neurol.2017.12.003_bib0520","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/jid.1962.10","article-title":"Sebum production and fractional 17-ketosteroid excretion in parkinsonism","volume":"38","author":"Pochi","year":"1962","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0525","first-page":"690","article-title":"Seborrhoeic dermatitis in a series of cases of postepidemic encephalitis","volume":"21","author":"Weidman","year":"1930","journal-title":"Arch Derm"},{"key":"10.1016\/j.neurol.2017.12.003_bib0530","first-page":"260","article-title":"Encehlitis ohne Lethargie wahrend der Grippeepidemie","volume":"39","author":"Cohn","year":"1920","journal-title":"Zbl Neurochir"},{"key":"10.1016\/j.neurol.2017.12.003_bib0535","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1990.tb08241.x","article-title":"The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders","volume":"122","author":"Cowley","year":"1990","journal-title":"Br Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0540","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1523-1747.ep12682040","article-title":"Sebaceous gland secretion in Parkinson's disease during L-dopa treatment","volume":"60","author":"Kohn","year":"1973","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0545","first-page":"311","article-title":"Effect of L-dopa on seborrhoea of Parkinsonism","volume":"2","author":"Burton","year":"1970","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neurol.2017.12.003_bib0550","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM197010152831622","article-title":"L-dopa for seborrheic dermatitis","volume":"283","author":"Parish","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2017.12.003_bib0555","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archderm.1971.04000170026005","article-title":"A new approach to the reduction of sebum secretion","volume":"103","author":"Harville","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0560","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-9877(03)00094-X","article-title":"Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links","volume":"60","author":"Mastrolonardo","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neurol.2017.12.003_bib0565","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0404.1994.tb01675.x","article-title":"Could seborrhoeic dermatitis be implicated in the pathogenesis of parkinsonism?","volume":"89","author":"O\u2019Neill","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2017.12.003_bib0570","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0404.1999.tb00654.x","article-title":"Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome","volume":"99","author":"Charlett","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2017.12.003_bib0575","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/DSS.0000000000000591","article-title":"A review of the association between parkinson disease and malignant melanoma","volume":"42","author":"Disse","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.neurol.2017.12.003_bib0580","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.parkreldis.2009.05.002","article-title":"Parkinson's disease, levodopa-use and the risk of melanoma","volume":"15","author":"Vermeij","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2017.12.003_bib0585","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.1978.03290060056015","article-title":"Levodopa therapy and malignant melanoma","volume":"240","author":"Sober","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2017.12.003_bib0590","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","article-title":"Atypical cancer pattern in patients with Parkinson's disease","volume":"92","author":"Olsen","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neurol.2017.12.003_bib0595","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4161\/cc.6.15.4511","article-title":"Autophagy and human disease","volume":"6","author":"Huang","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurol.2017.12.003_bib0600","doi-asserted-by":"crossref","first-page":"a009357","DOI":"10.1101\/cshperspect.a009357","article-title":"The role of autophagy in Parkinson's disease","volume":"2","author":"Lynch-Day","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neurol.2017.12.003_bib0605","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.semcancer.2013.07.001","article-title":"Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications","volume":"23","author":"Corazzari","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0610","doi-asserted-by":"crossref","first-page":"e10481","DOI":"10.1371\/journal.pone.0010481","article-title":"Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma","volume":"5","author":"Matsuo","year":"2010","journal-title":"Plos One"},{"key":"10.1016\/j.neurol.2017.12.003_bib0615","first-page":"108","article-title":"PARKIN inactivation links Parkinson's disease to melanoma","volume":"3","author":"Hu","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"1512","key":"10.1016\/j.neurol.2017.12.003_bib0620","first-page":"e5","article-title":"Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease","volume":"35","author":"Dong","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2017.12.003_bib0625","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/hmg\/ddt465","article-title":"Genetic comorbidities in Parkinson's disease","volume":"23","author":"Nalls","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2017.12.003_bib0630","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2017.12.003_bib0635","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.suc.2007.03.001","article-title":"Pathophysiology of inflammatory bowel disease: an overview","volume":"87","author":"Thoreson","year":"2007","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.neurol.2017.12.003_bib0640","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2017.12.003_bib0645","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0140-6736(02)08590-2","article-title":"Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study","volume":"359","author":"Hampe","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neurol.2017.12.003_bib0650","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1073\/pnas.91.26.12721","article-title":"Molecular evidence for two forms of Crohn disease","volume":"91","author":"Gilberts","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2017.12.003_bib0655","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/379821a0","article-title":"Mapping of a susceptibility locus for Crohn's disease on chromosome 16","volume":"379","author":"Hugot","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2017.12.003_bib0660","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/glia.20286","article-title":"Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes","volume":"53","author":"Sterka","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.neurol.2017.12.003_bib0665","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neures.2006.11.012","article-title":"CARD15 variants in patients with sporadic Parkinson's disease","volume":"57","author":"Bialecka","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neurol.2017.12.003_bib0670","doi-asserted-by":"crossref","first-page":"275","DOI":"10.12998\/wjcc.v3.i3.275","article-title":"Clinical and diagnostic aspects of gluten related disorders","volume":"3","author":"Tovoli","year":"2015","journal-title":"World J Clin Case"},{"key":"10.1016\/j.neurol.2017.12.003_bib0675","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.3390\/nu7105426","article-title":"The spectrum of differences between childhood and adulthood celiac disease","volume":"7","author":"Ciccocioppo","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.neurol.2017.12.003_bib0680","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/gut.2005.075119","article-title":"Recent advances in coeliac disease","volume":"55","author":"van Heel","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.neurol.2017.12.003_bib0685","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1568007043482552","article-title":"Transglutaminases - possible drug targets in human diseases","volume":"3","author":"Gentile","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.neurol.2017.12.003_bib0690","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2009.09.008","article-title":"Celiac disease: from pathogenesis to novel therapies","volume":"137","author":"Schuppan","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neurol.2017.12.003_bib0695","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.parkreldis.2015.05.015","article-title":"The association between infectious burden and Parkinson's disease: a case-control study","volume":"21","author":"Bu","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2017.12.003_bib0700","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1523-5378.2005.00331.x","article-title":"Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism","volume":"10","author":"Dobbs","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.neurol.2017.12.003_bib0705","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1053\/j.gastro.2005.11.046","article-title":"Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics","volume":"130","author":"Quigley","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neurol.2017.12.003_bib0710","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2017.12.003_bib0715","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.mehy.2014.09.025","article-title":"M. paratuberculosis and Parkinson's disease--is this a trigger","volume":"83","author":"Dow","year":"2014","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neurol.2017.12.003_bib0720","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0725","series-title":"Tetracyclines in Biology, Chemistry and Medicine","first-page":"267","article-title":"Inhibition of matrix metalloproteinases (MMPs) by tetracyclines","author":"Hanemaaijer","year":"2001"},{"key":"10.1016\/j.neurol.2017.12.003_bib0730","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model","volume":"61","author":"Lazzarini","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neurol.2017.12.003_bib0735","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cne.901010212","article-title":"The origin of intrinsic ganglia of trunk viscera from vagal neural crest in the chick embryo","volume":"101","author":"Yntema","year":"1954","journal-title":"J Comparative Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0740","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrgastro.2016.107","article-title":"The bowel and beyond: the enteric nervous system in neurological disorders","volume":"9","author":"Rao","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0745","series-title":"Review of medical embryology","author":"Pansky","year":"1982"},{"key":"10.1016\/j.neurol.2017.12.003_bib0750","series-title":"Neural crest cells","first-page":"3","article-title":"DE. The neural crest, a fourth germ layer of the vertebrate embryo: significance in chordate evolution","author":"Le Douarin","year":"2014"},{"key":"10.1016\/j.neurol.2017.12.003_bib0755","series-title":"Rook's Textbook of Dermatology","first-page":"424","article-title":"Genetics and genodermatoses","author":"Burns","year":"2008"},{"key":"10.1016\/j.neurol.2017.12.003_bib0760","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11745-009-3283-9","article-title":"Structures of the ceramides from porcine palatal stratum corneum","volume":"44","author":"Hill","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.neurol.2017.12.003_bib0765","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0770","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.4049\/jimmunol.179.7.4829","article-title":"Aging up-regulates expression of inflammatory mediators in mouse adipose tissue","volume":"179","author":"Wu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0775","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2017.12.003_bib0780","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444082","article-title":"Patients with rosacea have increased risk of depression and anxiety disorders: a Danish Nationwide Cohort Study","volume":"232","author":"Egeberg","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.neurol.2017.12.003_bib0785","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ana.24645","article-title":"Patients with rosacea have increased risk of dementia","volume":"79","author":"Egeberg","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2017.12.003_bib0790","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.14930","article-title":"Rosacea and gastrointestinal disorders - a population-based cohort study","volume":"1","author":"Egeberg","year":"2017","journal-title":"Br Dermatol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717306835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717306835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T19:25:46Z","timestamp":1544037946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378717306835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0035378717306835"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.12.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733849981.793549951","asserted-by":"object"}]},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease pathogenesis, evolution and alternative pathways: A review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}